Delivery Order SPE2DB22D1202-SPE2DB25FUGW7

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $33,097.99 and a period of performance through May 30, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. As a child contract, it is likely associated with a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,565.68, is for the delivery of the specialty medication MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed-price pricing type and an ultimate completion date of September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $23,354.20. The contract provides for the delivery of the medication MOUNJARO 10 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,265.08, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price contract. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the medication MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The fixed-price contract has a ceiling value of $14,159.94 and an ultimate completion date of August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,069.42 and is a firm-fixed-price delivery order, with an ultimate completion date of August 22, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, through its extensive supply chain network, will provide this...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the medication MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,052.00 and a completion date of May 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $16,257.11 and a period of performance through May 23, 2024. The award is for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of the medication MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $6,530.16 and a completion date of June 9, 2025. The contract is designated as a Firm Fixed Price delivery order, without any set-aside requirement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.54, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 18, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUGW7
    Delivery Order

This is a Delivery Order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $5,260.00 and is for the delivery of the medication MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of October 31, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was openly competed.

Generated 1/29/25, 9:26 AM